MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.
- Published In:
- International journal of molecular sciences, 23(19) (2022)
- Authors:
- Mohtashami, Zahra, Singh, Mithalesh K, Salimiaghdam, Nasim, Ozgul, Mustafa, Kenney, M Cristina
- Database ID:
- RPEP-06373
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06373APA
Mohtashami, Zahra; Singh, Mithalesh K; Salimiaghdam, Nasim; Ozgul, Mustafa; Kenney, M Cristina. (2022). MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.. International journal of molecular sciences, 23(19). https://doi.org/10.3390/ijms231911991
MLA
Mohtashami, Zahra, et al. "MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms231911991
RethinkPeptides
RethinkPeptides Research Database. "MOTS-c, the Most Recent Mitochondrial Derived Peptide in Hum..." RPEP-06373. Retrieved from https://rethinkpeptides.com/research/mohtashami-2022-motsc-the-most-recent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.